Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
Cardiovascular Toxicities of Cancer Therapies
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Demystifying Molecular-Based Tests in Head and Neck Cancers
Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. Themain focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patientswith head and neck cancers. This includes next generation sequencing assays for DNA sequencing, RNA sequencing, andcirculating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation ofthese tests.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Update on Prostate Cancer Screening
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Lymphoma Management Updates for 2021 - SPOC
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma.
Category
  • Research to Practice
Format
  • Non-Credit Course
Credits
  • 1.00 Participation
Update in Bladder Cancer
Matthew I. Milowsky, MD, FASCO, will present on Update in Bladder Cancer
Category
  • Research to Practice
Format
  • Live Webinars
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date September 25, 2024
Lymphoma Management in North Carolina
Anne W. Beaven, MD, will present on Lymphoma Management in North Carolina
Category
  • Research to Practice
Format
  • Live Webinars
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date October 23, 2024
Updates in Lung Cancer in North Carolina
Shetal Patel, MD, PhD, will present on Updates in Lung Cancer in North Carolina.
Category
  • Research to Practice
Format
  • Live Webinars
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date November 20, 2024
Head and Neck Cancer Management in North Carolina
Sumita Trivedi, MD, will present on Head and Neck Cancer Management in North Carolina
Category
  • Research to Practice
Format
  • Live Webinars
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 AMA PRA Category 1 Credit™ - Non-physician
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date December 18, 2024

Pages